Azaperone

CAS No. 1649-18-9

Azaperone ( Azaperone; Stresnil; Azaperon; Fluoperidol )

Catalog No. M18105 CAS No. 1649-18-9

Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 65 Get Quote
500MG 141 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Azaperone
  • Note
    Research use only, not for human use.
  • Brief Description
    Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine.
  • Description
    Azaperone is a dopamine antagonist. Azaperone is used mainly as a tranquilizer in veterinary medicine.
  • Synonyms
    Azaperone; Stresnil; Azaperon; Fluoperidol
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Kinesin
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1649-18-9
  • Formula Weight
    327.4
  • Molecular Formula
    C19H22FN3O
  • Purity
    98%
  • Solubility
    DMSO : 50 mg/mL 152.72 mM;H2O : < 0.1 mg/mL
  • SMILES
    FC1=CC=C(C=C1)C(=O)CCCN1CCN(CC1)C1=CC=CC=N1
  • Chemical Name
    1-(4-Fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. SSL Tan, et al. Appl Anim Behav Sci, 1990, 26(1-2), 157-168.
molnova catalog
related products
  • BRD 9876

    BRD 9876 is an ATP- and ADP-competitive Eg5 (kinesin-5) inhibitor with Ki of 4 nM.

  • S-Trityl-L-cysteine

    S-Trityl-L-cysteine (NSC 83265) is a potent, cell-permeable, selective inhibitor of mitotic kinesin Eg5, inhibits basal ATPase activity (IC50=1 mM) and microtubule-activated ATPase activity of Eg5 (IC50=140 nM).

  • WZ8040

    WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).